Valsartan D8
| Product Name | Valsartan D8 |
|---|---|
| Alternate Names | Valsartan Stable Isotopes, Stable Isotopes of Valsartan |
| CAT No. | CS-O-07051 |
| CAS No. | 1089736-72-0 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 443.57 g/mol |
| Mol. For. | C₂₄H₂₁D₈N₅O₃ |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Valsartan |
| Purity | 95% |
| Therapeutic | Anti-Hypertensives |
| Smileys | [2H][C@@](C(=O)O)(C([2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(=O)CCCC |
| Canonical Smiles | CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O |
| InchIKey | ACWBQPMHZXGDFX-KFWZLTATSA-N |
| Inchl | InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1/i2D3,3D3,16D,22D |
| IUPAC | (2S)-2,3,4,4,4-pentadeuterio-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-3-(trideuteriomethyl)butanoic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Valsartan D8 is a deuterated form of Valsartan, a medication used to treat high blood pressure, heart failure, and to reduce the risk of death after a heart attack. Valsartan D8 contains eight deuterium atoms, which can improve its pharmacokinetics by increasing its stability and reducing the rate of metabolism in the body. This can lead to a longer half-life and more consistent plasma concentration levels, resulting in improved therapeutic efficacy.
Chemically, Valsartan D8 is an angiotensin II receptor antagonist. It works by blocking the binding of angiotensin II to its receptors, causing blood vessels to dilate and reducing blood pressure. This drug is metabolized by the liver and excreted through the kidneys.
Valsartan D8 is administered orally, usually once or twice daily. The recommended dosage varies depending on the patient's age, weight, and medical condition. Common side effects of Valsartan D8 include dizziness, headache, fatigue, and diarrhea. In rare cases, it may cause allergic reactions, liver problems, or kidney failure.
Overall, Valsartan D8 is a useful medication for treating high blood pressure and heart failure. Its deuterated form may offer improved pharmacokinetics and therapeutic efficacy. As with any medication, it should only be taken under the guidance of a healthcare professional.
Get an Instant Quote
Related Compounds
Valsartan D3 | Valsartan D9 |